R2033004 |
Derazantinib |
Derazantinib (ARQ-087) is an ATP competitive tyrosine kinase inhibitor; exhibits
|
R2033005 |
DGAT1-IN-1 |
DGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of < 10 nM(cell lysate from
|
R2033006 |
GNE-490 |
GNE-490 is a highly selective pan-PI3K inhibitor that demonstrates selectivity o
|
R2033007 |
GSK-F1 |
GSK-F1 is a potent inhibitor of PI4KA.It has markedly better pharmacokinetic pro
|
R2033008 |
GW441756 |
GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC
|
R2033009 |
GW806742X |
GW806742X is a Mixed Lineage Kinase Domain-Like protein (MLKL) inhibitor which b
|
R2033010 |
JBSNF-000088 |
JBSNF-000088 (6-Methoxynicotinamide), a analog of nicotinamide (NA), is a potent
|
R2033011 |
JNJ-38158471 |
JNJ-38158471 is a well tolerated, orally available, highly selective VEGFR-2 inh
|
R2033012 |
LXH254 |
LXH254 is a potent B/C RAF inhibitor extracted from patent WO2018051306A1, Compo
|
R2033013 |
LY2510924 |
LY2510924 is a potent and selective CXCR4 antagonist that blocks SDF-1 binding t
|
R2033014 |
MBP146-78 |
MBP146-78 is a potent and selective inhibitor of cGMP dependent protein kinases.
|
R2033015 |
MI463 |
MI-463 is a highly potent and orally bioavailable small molecule inhibitor of th
|
R2033016 |
MI503 |
MI-503 is a highly potent and orally bioavailable small molecule inhibitor of th
|
R2033017 |
MPI-5a |
MPI_5a is a potent and selective HDAC6 inhibitor (IC50=36 nM).MPI_5a weakly inhi
|
R2033018 |
NIBR-17 |
NIBR-17 is a pan class I PI3K inhibitor with IC(50) values of 1, 9.2, 9 and 20nM
|
R2033019 |
PF-04979064 |
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with Kis o
|
R2033020 |
PF4618433 |
PF 4618433 is an inhibitor of proline-rich tyrosine kinase 2 (PYK2) and focal ad
|
R2033021 |
RO495 |
RO495 is a very potent TYK2 inhibitor with a IC50 of 1.5nM on TYK2 as tested in
|
R2033022 |
S6K-18 |
S6K-18 is a highly selective inhibitor of S6K1, with an IC50 of 52nM.
|
R2033023 |
SSR240612 |
SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 rece
|
R2033024 |
Takeda-6d |
Takeda-6d has potent inhibitory activity in both B-RAF with an IC50 of 7.0 nM an
|
R2033025 |
AZ3451 |
AZ3451 is a potent protease-activated receptor-2 (PAR2) antagonist with IC50 of
|
R2033026 |
Acumapimod |
Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 o
|
R2033027 |
AZD7986 |
AZD7986 is a Dipeptidyl peptidase 1 (DPP1) inhibitor with pIC50s of 6.85, 7.6, 7
|
R2033028 |
VU0155069 |
VU0155069 (CAY10593), compound 69, is a selective phospholipase D1 (PLD1) inhibi
|